Literature DB >> 7846211

Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety.

G A Kennett1, K Pittaway, T P Blackburn.   

Abstract

Four non-selective 5-HT2C/5-HT2A receptor antagonists, mianserin (2-8 mg/kg), 1-naphthyl piperazine (1-NP) (0.5-1 mg/kg), ICI 169,369 (20 mg/kg) and LY 53857 (5 mg/kg), increased punished responding for a food reward in the rat Geller-Seifter test 30 min after subcutaneous (SC) administration. This property was shared by the benzodiazepine anxiolytic chlordiazepoxide (5 mg/kg SC). However, the selective 5-HT2A receptor antagonists ketanserin (0.2-1 mg/kg SC) and altanserin (0.5, 1 mg/kg SC) had little effect. The 5-HT1A, 5-HT1B and beta-adrenergic receptor antagonists pindolol and cyanopindolol (6 mg/kg SC) did not affect punished responding either, nor did the 5-HT1D receptor partial agonist and alpha 2 adrenergic receptor antagonist yohimbine (2.5 mg/kg SC) or the histamine H1 receptor antagonist mepyramine (1 mg/kg SC). Unpunished responding was also modestly increased after some doses of the 5-HT2C/5-HT2A receptor antagonists. However, this effect was inconsistent and was also seen after chlordiazepoxide. Furthermore, it was not associated with the increase in punished responding observed in rats orally treated with mianserin (10, 20 mg/kg), 1-NP (10, 20 mg/kg) or ICI 169,369 (50 mg/kg). The action of the 5-HT2C/5-HT2A receptor antagonists tested is therefore consistent with anxiolysis. The results also strongly suggest that this effect is mediated by blockade of the 5-HT2C receptor, although the possibility of 5-HT2B receptor mediation is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7846211     DOI: 10.1007/bf02245448

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  54 in total

1.  Zacopride: anxiolytic profile in rodent and primate models of anxiety.

Authors:  B Costall; A M Domeney; P A Gerrard; M E Kelly; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1988-04       Impact factor: 3.765

2.  5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

Review 3.  Serotonin and anxiety revisited.

Authors:  R S Kahn; H M van Praag; S Wetzler; G M Asnis; G Barr
Journal:  Biol Psychiatry       Date:  1988-01-15       Impact factor: 13.382

4.  Comparative double-blind trial of mianserin hydrochloride (Organon GB94) and diazepam in patients with depressive illness.

Authors:  G F Russell; U Niaz; A Wakeling; P D Slade
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

5.  Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants.

Authors:  P Mason; J Skinner; D Luttinger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Tryptamine antagonists and punished behavior.

Authors:  F G Graeff
Journal:  J Pharmacol Exp Ther       Date:  1974-05       Impact factor: 4.030

7.  5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model.

Authors:  G A Kennett
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  A controlled comparative trial of mianserin and diazepam in the treatment of anxiety states in psychiatric out-patients.

Authors:  L Conti; R M Pinder
Journal:  J Int Med Res       Date:  1979       Impact factor: 1.671

9.  Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

10.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

View more
  14 in total

1.  (+/-)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites and serotonin-1A receptors.

Authors:  M Reyes-Parada; C Scorza; V Romero; R Silveira; J H Medina; D Andrus; D E Nichols; B K Cassels
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

Review 2.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

3.  Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models.

Authors:  A J Cross; D Widzowski; C Maciag; A Zacco; T Hudzik; J Liu; S Nyberg; M W Wood
Journal:  Br J Pharmacol       Date:  2015-12-01       Impact factor: 8.739

4.  Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.

Authors:  Francis Rodriguez Bambico; Tommaso Cassano; Sergio Dominguez-Lopez; Noam Katz; Claire Dominique Walker; Daniele Piomelli; Gabriella Gobbi
Journal:  Neuropsychopharmacology       Date:  2010-06-23       Impact factor: 7.853

5.  Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.

Authors:  Antonio Pedro de Mello Cruz; Gilson Pinheiro; Sérgio Henrique Alves; Graziela Ferreira; Marília Mendes; Letícia Faria; Carlos Eduardo Macedo; Vitor Motta; J Landeira-Fernandez
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

6.  Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety.

Authors:  G A Kennett; F Bailey; D C Piper; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

7.  Blockade of 5-HT(2A) and/or 5-HT(2C) receptors modulates sevoflurane-induced immobility.

Authors:  Hirokazu Nagatani; Tsutomu Oshima; Akiyoshi Urano; Yuhji Saitoh; Miyuki Yokota; Yoshinori Nakata
Journal:  J Anesth       Date:  2011-02-26       Impact factor: 2.078

8.  A 5-HT(2C) receptor antagonist potentiates a low dose amphetamine-induced conditioned place preference.

Authors:  John D McCorvy; Aubrie A Harland; Rebecca Maglathlin; David E Nichols
Journal:  Neurosci Lett       Date:  2011-07-30       Impact factor: 3.046

9.  Strategies for the synthesis of novel indole alkaloid-based screening libraries for drug discovery.

Authors:  Demosthenes Fokas; Libing Yu; Carmen M Baldino
Journal:  Mol Divers       Date:  2005       Impact factor: 2.943

10.  In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties.

Authors:  G A Kennett; M D Wood; F Bright; J Cilia; D C Piper; T Gager; D Thomas; G S Baxter; I T Forbes; P Ham; T P Blackburn
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.